标题 |
An acquired CCDC6:: RET gene fusion as resistance mechanism for Osimertinib in exon 21 EGFR(L858R) -mutated non-small cell lung cancer and its successful management with Osimertinib and Selpercatinib: a case report and review of literature
获得性CCDC6::RET基因融合作为外显子21 EGFR(L858R)突变的非小细胞肺癌奥希替尼耐药机制及其奥希替尼和Selpercatinib的成功治疗:病例报告和文献复习
|
网址 | |
DOI | |
其它 |
期刊:Journal of Chemotherapy 作者:Maud Lormans; Peter Van Haecke; Ingel Demedts 出版日期:2025 |
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |